Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Reexamination Certificate
2005-12-27
2005-12-27
Minnifield, N. M. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
C424S266100, C424S184100, C424S191100, C424S093100
Reexamination Certificate
active
06979451
ABSTRACT:
Vaccines and methods for inducing an immune response in a ruminant. The vaccine composition including pathogen and tick-derived antigens and a carrier or diluent. The method for inducing an immune response in a ruminate to provide immune protection which reduces the infection of ticks byA. marginaleand/or prevents the transmission of the pathogen includes the steps of administering to the ruminant an effective amount of the vaccine composition having at least one antigen member of the group comprising at least one antigen member of the group comprising (i) recombinant MSP1a surface protein antigen ofA. marginale, (ii) a subunit of recombinant MSP1a surface protein antigen ofA. marginaleand (iii) recombinant MSP1a surface protein antigen or subunits thereof in combination with antigen preparation derived fromA. marginaleinfected cultured tick IDE8 cells and/or other pathogen and tick-derived antigens, and a carrier or diluent.
REFERENCES:
patent: 3674860 (1972-07-01), Welter et al.
patent: 4956278 (1990-09-01), Hart et al.
patent: 5549898 (1996-08-01), McGuire et al.
patent: 5798219 (1998-08-01), Knowles et al.
patent: 5869335 (1999-02-01), Munderloh et al.
patent: 6025338 (2000-02-01), Barbet et al.
patent: 6242571 (2001-06-01), Knowles et al.
patent: 2002/0127242 (2002-09-01), de la Fuente et al.
patent: 196290 (1986-10-01), None
patent: 0196290 (1986-10-01), None
patent: WO97/08296 (1997-03-01), None
patent: WO 97/08296 (1997-03-01), None
de la Fuente et al, Expert Rev. Vaccines, 2003, 2/4:583-593.
Almazan et al, Vaccine, 2003, 21:1492-1501.
de la Fuente et al, Vet. Microbiology, 2002, 89:239-251.
Camacho-Nuez et al Infection and Immunity 68/4:1946-1952, Apr. 2000.
Brown et al, Infection and Immunity 66/11:5414-5422, Nov. 1998.
Palmer et al Infection and Immunity 50/3:881-886, Dec. 1985.
Arulkanthan et al, Infection and Immunity 67/7:3481-3487, Jul. 1999.
McGuire et al, Vaccine, 12/5:465-471, 1994.
Bowie et al, Gene, 282:95-102, 2002.
Brown et al, Infection and Immunity 69/11:6853-6862, Nov. 2001.
de la Fuente et al, International J Parasitology 31:1705-1714, 2001.
Palmer et al, Parasitology Today 15/7:281-286, 1999.
Vidotto et al, Infection and Immunity, 62/7:2940-2946, Ju. 1994.
de la Fuente, J., J.C. Garcia-Garcia, E.F. Blouin, S.D. Rodriguez, M.A. Garcia, and K.M. Kocan. 2001. Evolution and function of tandem repeats in the major surface protein 1a of the ehrlichial pathogenAnaplasma marginale. Animal Health Research Reviews. 2:2:163-173.
de la Fuente, J., J.C. Garcia-Garcia, E.F. Blouin, B.R. McEwen, D. Clawson, and K.M. Kocan. 2001. Major surface protein 1a effects tick infection and transmission of the ehrlichial pathogenAnaplasma marginale. International Journal for Parasitology. 31:1705-1714.
de la Fuente, J., J.C. Garcia-Garcia, E.F. Blouin, and K.M. Kocan. 2003, Characterization of the functional domain of major surface protein 1a involved in adhesion of the rickettsiaAnaplasma marginateto host cells.Veterinary Microbiology. 91:265-283.
de la Fuente, J., K.M. Kocan, J.C. Garcia-Garcia, E.F. Blouin, P.L. Claypool, and J.T. Saliki. 2002. Vaccination of cattle withAnaplasma marginalederived from tick cell culture and bovine erythrocytes followed by challenge-exposure by infected ticks.Veterinary Microbiology, 89:239-251.
Eid, G., D.M. French, A.M. Lundgren, A.F. Barbet, T.F. McElwain, and G.H. Palmer. 1996. Expression of Major Surface Protein 2 Antigenic Variants during AcuteAnaplasma marginaleRickettsemia.Infection and Immunity. 64:3:836-841.
Kocan, K.M. 1986. Development ofAnaplasma marginaleTheiler in ixodid ticks: Coordinated development of rickettsial organisms and its tick host. In: Sauer Jr, Hair JA, editors.Morphology, Physiology and Behavioral Ecology of Ticks. Chichester: Horwood, pp. 472-505.
Kocan, K.M., E.F. Blouin, G.H. Palmer, I.S. Eriks, W.L. Edwards, and P.L. Claypool. 1996. Preliminary studies on the effect ofAnaplasma marginaleantibodies ingested byDermacentor andersoniticks (Acari:Ixodidae) with their blood meal on infections in salivary glands.Experimental&Applied Acarology. 20:297-311.
Arulkanthan, A., W.C. Brown, T.C. McGuire, and D.P. Knowles. 1999. Biased Immunoglobulin G1 Isotype Responses Induced in Cattle with DNA Expressingmsp1a ofAnaplasma marginale.Infection and Immunity. 67:7:3481-3487.
Barbet, A.F., R. Blentlinger, J. Yi, A.M. Lundgren, E.F. Blouin, and K.M. Kocan. 1999. Comparison of surface proteins ofAnaplasma marginalegrown in tick cell culture, tick salivary glands, and cattle.Infection and Immunity. 67:1:102-107.
Blouin, E.F., J.T. Saliki, J. de la Fuente, J.C. Garcia-Garcia, K.M. Kocan. 2002b. Antibodies toAnaplasma marginalemajor surface protein 1a and 1b inhibit infectivity for cultured tick cells.Veterinary Parasitology. 111:247-260.
Bowie, M.V., J. de la Fuente, K.M. Kocan, E.F. Bouin, and A.F. Barbet. 2002. Conservation of major surface protein 1 genes ofAnaplasma marginaleduring cyclic transmission between ticks and cattle.Gene282:95-102.
Brown, W.C., D. Zhu, V. Shkap, T.C. McGuire, E.F. Blouin, K.M. Kocan, and G.H. Palmer. 1998. The Repertoire ofAnaplasma marginaleAntigens Recognized by CD4+T-Lymphocyte Clones from Protectively Immunized Cattle Is Diverse and Includes Major Surface Protein 2 (MSP-2) and MSP-3.Infection and Immunity, 66:11:5414-5422.
Brown, W.C., G.H. Palmer, H.A. Lewin, and T.C. McGuire. 2001. CD4+T Lymphocytes from Calves Immunized withAnaplasma marginaleMajor Surface Protein 1 (MSP1), a Heteromeric Complex of MSP1a and MSP1b, Preferentially Recognize the MSP1a Carboxyl Terminus That Is Conserved among Strains.Infection and Immunity. 69:11:6853-6862.
Camacho-Nuez, M., M. de L. Muñoz, C.E. Suarez, T.C. McGuire, W.C. Brown, and G.H. Palmer. 2000. Expression of Polymorficmsp1βGenes during AcuteAnaplasma marginaleRickettsemia.Infection and Immunity, 68:4:1946-1952.
Kocan, K.M., T. Halbur, E.F. Blouin, V. Onet, J. de la Fuente, J.C. Garcia-Garcia, and J.T. Saliki. 2001. Immunization of cattle withAnaplasma marginalederived from tick cell culture.Veterinary Parasitology. 102:151-161.
McGuire, T.C., E.B. Stephens, G.H. Palmer, T.F. McElwain, C.A. Lichtensteiger, S.R. Leib, and A.F. Barbet. 1994. Recombinant vaccinia virus expression ofAnaplasma marginalesurface protein MSP-1a: effect of promoters, leader sequences and GPI anchor sequence on antibody response.Vaccine. 12:5:465-471.
Montenegro-James, S., M.A. James, M. Toro Benitez, E. Leon, B.K. Baek, and A.T. Guillen. 1991. Efficacy of purifiedAnaplasma marginaleinitial bodies as a vaccine against anaplasmosis.Parasitology Research. 77:93-101.
Palmer, G.H., K.M. Kocan, S.J. Barron, J.A. Hair, A.F. Barbet, W.C. Davis, and T.C. McGuire. 1985. Presence of Common Antigens, Including Major Surface Protein Epitopes, between the Cattle (Intraerythrocytic) and Tick Stages andAnaplasma marginale. Infection and Immunity. 50:3:881-886.
Palmer, G.H., F.R. Rurangirwa, K.M. Kocan, and W.C. Brown. 1999. Molecular Basis for Vaccine Development against the Ehrlichial PathogenAnaplasma marginale. Parasitology Today. 15:7:281-286.
Palmer, G.H., F.R. Rurangirwa, and T.F. McElwain. 2001. Strain Composition of the EhrlichiaAnaplasma marginalewithin Persistently Infected Cattle, a Mammalian Reservoir for Tick Transmission.Journal of Clinical Microbiology. 39:2:631-635.
Vidotto, M.C., T.C. McGuire, T.F. McElwain, G.H. Palmer, and D.P. Kowles, Jr. 1994. Intermolecular Relationships of Major Surface Proteins ofAnaplasma marginale. Infection and Immunity. 62:7:2940-2946.
Allred DR, McGuire TC, Palmer GH, Leib SR, Harkins TM, McElwain TF, Barbet AF. Molecular basis for surface antigen size polymorphisms and conservation of a neutralization-sensitive epitope inAnaplasma marginale. Proc Natl Acad Sci USA 1990; 87: 3220-3224.
Barbet AF, Blentlinger R, Jooyoung Y, Lundgren AM, Blouin EF, Kocan KM. Comparison of surface proteins ofAnaplasma marginalegrown in tick cell culture, tick salivary glands, and cattle. Infect Immun 1999; 67:102-107.
Barbet AF, Palmer GH, Myler PJ, McGuire TC. Characterization of an immunoprotective protein complex ofAnaplasma marginaleby cloning and e
Blouin Edmour F.
de la Fuente Jose de Jesus
Garcia-Garcia Jose Carlos
Kocan Katherine M.
Fellers Snider Blankenship Bailey & Tippens, P.C.
Minnifield N. M.
The Board of Regents for Oklahoma State University
LandOfFree
Recombinant antigen MSP1a from anaplasma marginale to reduce... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant antigen MSP1a from anaplasma marginale to reduce..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant antigen MSP1a from anaplasma marginale to reduce... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3512780